NICE’s thumbs-up on Lilly’s migraine med Emgality leaves rivals from Novartis and Teva in the dust

NICE’s thumbs-up on Lilly’s migraine med Emgality leaves rivals from Novartis and Teva in the dust
arlene.weintraub
Wed, 11/18/2020 – 10:18